Anzeige
Mehr »
Freitag, 30.01.2026 - Börsentäglich über 12.000 News
Über 2 Mio. Unzen Gold - und trotzdem erst 59 Mio. USD Börsenwert?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
162 Leser
Artikel bewerten:
(1)

Rubinstein Plastic Surgery Center: Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein

Dr. Ran Rubinstein discusses how individualized treatment planning determines when fillers, neurotoxins, or collagen-stimulating injectables are most appropriate.

MONTVALE, NEW JERSEY / ACCESS Newswire / January 30, 2026 / Injectable aesthetic treatments continue to grow in popularity, yet confusion remains around when dermal fillers are appropriate versus when neurotoxins are the better option. Facial plastic surgeon and national injectables trainer Dr. Ran Rubinstein emphasizes that understanding how these treatments differ is essential to achieving natural, balanced results.

As a board-certified facial plastic surgeon certified by the American Board of Facial Plastic and Reconstructive Surgery, Dr. Rubinstein notes that fillers and neurotoxins work through distinct biological mechanisms and must be selected based on facial anatomy, movement patterns, and long-term aesthetic goals.

Dr. Ran Rubinstein is a board-certified facial plastic surgeon specializing exclusively in facial procedures and facial injectables.

Fillers and Neurotoxins Serve Different Purposes

Although both fillers and neurotoxins are injectable treatments, they address facial aging in fundamentally different ways.

Dermal fillers, most commonly injectable hyaluronic acid (HA) fillers, are designed to add volume, restore contour, or enhance facial definition. Neurotoxins, such as botulinum toxin products, work by relaxing targeted muscles to soften expression-related lines. While both treatments can improve the appearance of wrinkles, they do so through distinct processes that require different planning considerations.

Not All Dermal Fillers Are the Same

One of the most common misconceptions Dr. Rubinstein encounters is the belief that all injectable HA fillers function the same way. In practice, dermal fillers vary widely in texture, flexibility, and structural support, which is why careful product selection is essential.

Different HA fillers are selected based on:

  • The specific area of the face being treated

  • The amount of movement in that area

  • Whether the goal is subtle refinement or structural support

Some fillers are soft and flexible to accommodate natural facial movement, while others provide firmer support for contouring and definition. Proper product selection allows results to look balanced and natural rather than overfilled. This individualized approach to dermal fillers reflects the importance of injector expertise and facial anatomy knowledge.

Biostimulators and HA Fillers Are Not Interchangeable

Another area of confusion involves biostimulators and their role in facial rejuvenation. While biostimulators and injectable hyaluronic acid (HA) fillers are often discussed together, they serve different purposes and are selected based on distinct treatment goals.

Biostimulatory injectables are designed to stimulate the body's natural collagen production over time. Rather than creating immediate volume, they support gradual structural improvement and skin quality changes as collagen develops. For many patients, this approach offers:

  • More subtle, progressive enhancement

  • Longer-lasting improvement driven by collagen remodeling

  • A natural evolution of results over time rather than instant change

Because collagen production occurs gradually, biostimulatory treatments may require multiple sessions and patience before results are fully visible. They are often chosen for patients seeking long-term support rather than immediate contour correction.

Injectable HA fillers, by contrast, are frequently used when precise placement and immediate volume or definition are desired. Their ability to deliver targeted structural support makes them well suited for specific facial areas where contour and balance need to be addressed directly.

Understanding the complementary roles of biostimulators and HA fillers allows treatment plans to be tailored rather than standardized, ensuring each approach is used where it delivers the most appropriate and natural outcome.

Understanding Cost, Longevity, and Value

Concerns about cost often influence patient decision-making. Dr. Rubinstein notes that injectable treatments should be evaluated based on longevity, precision, and outcomes rather than upfront pricing alone.

Most injectable HA filler treatments are performed in-office in under an hour, with results that may last a year or longer depending on the product used and the treatment area. When considered over time, many patients find that the durability and quality of results justify the investment.

Fillers Are Used Beyond the Lips

Dermal fillers are frequently associated only with lip enhancement, but their applications extend far beyond that single area. Injectable HA fillers can be used to address a range of facial concerns, including:

  • Under-eye hollowing

  • Cheek contour and midface volume

  • Lower facial lines and folds

  • Chin structure and projection

Each treatment area requires careful evaluation of facial proportions and product selection to maintain harmony across the face.

The Key Difference Between Fillers and Neurotoxins

A foundational distinction Dr. Rubinstein emphasizes is how fillers and neurotoxins achieve their effects.

Fillers add volume or definition and often produce immediate visible changes. Neurotoxins reduce muscle movement, with results developing gradually over several days to weeks. While both treatments can smooth lines or wrinkles, they address different causes of facial aging and are frequently used together as part of a comprehensive treatment plan.

Expertise Matters in Injectable Treatment Planning

Dr. Rubinstein's approach to injectables is rooted in education, safety, and anatomical precision. As a national trainer, he works with medical professionals across the country to advance best practices in aesthetic injection techniques. This role underscores the importance of individualized treatment planning and ongoing education in a rapidly evolving field.

Located in Montvale, New Jersey, Rubinstein Plastic Surgery Center focuses exclusively on facial plastic surgery and facial rejuvenation procedures. The practice offers injectable treatments designed to enhance facial balance while preserving natural expression.

Educational insights and professional updates from Dr. Rubinstein are shared through the practice's official Instagram account, where injectable concepts and facial anatomy considerations are discussed for both patients and medical professionals.

Patients interested in learning more about facial injectables or scheduling a consultation can connect with the practice through the contact page.

About Dr. Ran Rubinstein

Dr. Ran Rubinstein is a board-certified facial plastic surgeon specializing exclusively in facial procedures and facial injectables. He is certified by the American Board of Facial Plastic and Reconstructive Surgery and trained in Otolaryngology-Head and Neck Surgery. Dr. Rubinstein is recognized nationally as an injectables trainer and educator, with a focus on precision, safety, and natural-appearing results.

Media Contact
Dr. Ran Rubinstein
(201) 391-1135
info@rubinsteinplasticsurgerycenter.com

SOURCE: Rubinstein Plastic Surgery Center



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/understanding-when-to-use-fillers-or-neurotoxins-according-to-dr.-ran-1131622

© 2026 ACCESS Newswire
Gold & Silber auf Rekordjagd
Kaum eine Entwicklung war 2025 so eindrucksvoll wie der Höhenflug der Edelmetalle. Allen voran Silber: Angetrieben von einem strukturellen Angebotsdefizit, explodierte der Preis und übertrumpfte dabei den „großen Bruder“ Gold. Die Nachfrage aus dem Investmentsektor zieht weiter an, und ein Preisziel von 100 US-Dollar rückt in greifbare Nähe.

Auch Gold markierte neue Meilensteine. Mit dem Durchbruch über 3.000 und 4.000 US-Dollar pro Unze hat sich der übergeordnete Aufwärtstrend eindrucksvoll bestätigt. Rücksetzer bleiben möglich, doch der nächste Zielbereich bei 5.000 US-Dollar ist charttechnisch fest im Blick. Die fundamentalen Treiber sind intakt, eine nachhaltige Trendwende aktuell nicht in Sicht.

Für Anlegerinnen und Anleger bedeutet das: Jetzt ist die Zeit, um gezielt auf starke Produzenten zu setzen. In unserem neuen Spezialreport stellen wir fünf Gold- und Silberaktien vor, die trotz Rallye weiter attraktives Potenzial bieten, mit robusten Fundamentaldaten und starken Projekten in aussichtsreichen Regionen.

Jetzt den kostenlosen Report sichern und von der nächsten Welle im Edelmetall-Boom profitieren!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.